Schnell Biopharmaceuticals Inc. | Ownership
Companies that own Schnell Biopharmaceuticals Inc.
The Vanguard Group, Inc.
1,777,277
1.65%
44
0%
07/31/2018
BlackRock Fund Advisors
1,372,943
1.27%
0
0%
09/05/2018
Norges Bank Investment Management
432,798
0.4%
254,597
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
222,455
0.21%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
167,197
0.16%
44,518
0.01%
04/30/2018
Charles Schwab Investment Management, Inc.
134,508
0.13%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
47,013
0.04%
0
0%
03/31/2018
SSgA Funds Management, Inc.
45,540
0.04%
0
0%
09/06/2018
Samsung Asset Management Co., Ltd.
25,196
0.02%
18,270
0.01%
07/06/2018
State Street Global Advisors Ltd.
6,670
0.01%
0
0%
09/05/2018
| Address |
Room 301 Gangho Building
Seoul SL 06735
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.aprogen-pharm.com |
| Updated |
07/08/2019 |
| Aprogen Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical products. It operates throught the Pharmaceutical Manufacturing and Wholesale business divisions. The Pharmaceutical Manufacturing division provides antibiotics, antirhematics, and medicines for dermatopathy. |
